|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome显示文摘The use of small interfering RNAs(si RNAs)has been under investigation for the treatment of several unmet medical needs,including acute lung injury/acute respiratory distress syndrome(ALI/ARDS)wherein si RNA may be implemented to modify the expression of pro-inflammatory cytokines and chemokines at the m RNA level.The properties such as clear anatomy,accessibility,and relatively low enzyme activity make the lung a good target for local si RNA therapy.However,the translation of si RNA is restricted by the inefficient delivery of si RNA therapeutics to the target cells due to the properties of naked si RNA.Thus,this review will focus on the various delivery systems that can be used and the different barriers that need to be surmounted for the development of stable inhalable si RNA formulations for human use before si RNA therapeutics for ALI/ARDS become available in the clinic. | Makhloufi Zoulikha Qingqing Xiao George Frimpong Boafo Marwa A.Sallam Zhongjian Chen Wei He | 2022 | Acta Pharmaceutica Sinica B2022，12，2： | 7 |
| 2 | Metal phenolic network-stabilized nanocrystals of andrographolide to alleviate macrophage-mediated inflammation in-vitro显示文摘Macrophages play a crucial role in initiating,maintaining,and resolving inflammation through the phenotypic shift,inducing or inhibiting the production of inflammatory cytokines.Therefore,macrophages are potential targets for treating inflammatory diseases.Andrographolide(AND)is a potent anti-inflammatory drug that can reduce pro-inflammatory cytokines and suppress NF-κB/MAPK pathway in activated macrophages.Although AND has many medicinal properties,its lower water solubility and first-pass effect in the liver have hindered its clinical application.In this context,by using a metal phenolic network as a stabilizer,we designed and prepared highly stabilized AND nanocrystals(AND-MPN Ns)with high drug loading capacity to facilitate the clinical application of AND.Our findings showed that AND-MPN Ns could be used to enhance the anti-inflammation in-vitro via macrophage polarization,reducing proinflammatory cytokines IL-6 and TNF-α,and suppressing the NF-κB signaling pathway activation.The results demonstrated the potential of AND-MPN Ns to combat inflammatory diseases effectively. | Kosheli Thapa Magar George Frimpong Boafo Makhloufi Zoulikha Xiaohong Jiang Xiaotong Li Qingqing Xiao Xuyang Xing Xiaochun Wang Lifang Fan Zhenfeng Wu Wei He | 2023 | Chinese Chemical Letters2023，34，1： | 2 |
| 3 | Liposome-based delivery of biological drugs显示文摘Biological drugs are attracting tremendous attention in disease treatment. However, their application is significantly limited by their inherent properties, such as high hydrophilicity, poor membranepermeability, low stability, and larger size. Liposome-based drug delivery systems are emerging as promising tools to improve their delivery, owing to their ability to reduce toxicity, improve bioavailability,and enhance the therapeutic efficacy of the drug by optimizing delivery to the specific target site. Here,we reviewed the types of liposomes and their applications as carriers for biological drugs to treat various diseases, emphasized the commercial products, and ultimately provided perspectives in this field. | Kosheli Thapa Magar George Frimpong Boafo Xiaotong Li Zhongjian Chen Wei He | 2022 | Chinese Chemical Letters2022，33，2： | 1 |
| 4 | A novel Ir–Zr gradient coating prepared on Mo substrate by double glow plasma显示文摘 | Xiangna Cong Zhaofeng Chen Wangping Wu Jiang Xu Fred Edmond Boafo | 2012 | Applied Surface Science2012，，12： | 1 |
| 5 | Effect of pres- sure holding time of extraction process on thermal conductivity of glass fiber VIPs显示文摘 | LiCD ChenZF Boafo FE | 2014 | Journal of Mate- rials Processing Technology2014，214，3： | 1 |
| 6 | Multifunctional nanoparticle-mediated combining therapy for human diseases显示文摘Combining existing drug therapy is essential in developing new therapeutic agents in disease prevention and treatment.In preclinical investigations,combined effect of certain known drugs has been well established in treating extensive human diseases.Attributed to synergistic effects by targeting various disease pathways and advantages,such as reduced administration dose,decreased toxicity,and alleviated drug resistance,combinatorial treatment is now being pursued by delivering therapeutic agents to combat major clinical illnesses,such as cancer,atherosclerosis,pulmonary hypertension,myocarditis,rheumatoid arthritis,inflammatory bowel disease,metabolic disorders and neurodegenerative diseases.Combinatorial therapy involves combining or co-delivering two or more drugs for treating a specific disease.Nanoparticle(NP)-mediated drug delivery systems,i.e.,liposomal NPs,polymeric NPs and nanocrystals,are of great interest in combinatorial therapy for a wide range of disorders due to targeted drug delivery,extended drug release,and higher drug stability to avoid rapid clearance at infected areas.This review summarizes various targets of diseases,preclinical or clinically approved drug combinations and the development of multifunctional NPs for combining therapy and emphasizes combinatorial therapeutic strategies based on drug delivery for treating severe clinical diseases.Ultimately,we discuss the challenging of developing NP-codelivery and translation and provide potential approaches to address the limitations.This review offers a comprehensive overview for recent cutting-edge and challenging in developing NP-mediated combination therapy for human diseases. | Xiaotong Li Xiuju Peng Makhloufi Zoulikha George Frimpong Boafo Kosheli Thapa Magar Yanmin Ju Wei He | 2024 | Signal Transduction and Targeted Therapy2024，9，2： | 0 |
| 7 | Mass-transfer studies of solid-base catalyst-aided CO_(2) absorption and solid-acid catalyst-aided CO_(2) desorption for CO_(2) capture in a pilot plant using aqueous solutions of MEA and blends of MEA-MDEA and BEA-AMP显示文摘Mass-transfer studies of catalyst-aided CO_(2) absorption and desorption were performed in a full-cycle,bench-scale pilot plant to improve CO_(2) absorption using 5M MEA,5M MEA-2M MDEA and 2M BEA-2M AMP.A solid-base catalyst,K/MgO,and an acid catalyst,HZSM-5,were used to facilitate absorption and desorption,respectively.Absorption and desorption mass-transfer performance was presented in terms of the overall mass-transfer coefficient of the gas side(KGav)and liquid side(K_(L)a_(v)),respectively.For non-catalytic runs,the highest K_(G)a_(V) and K_(L)a_(V) were 0.086 Kmol m^(3).kPa.hr and 0.7851 hr for 2M BEA-2M AMP solvent.The results showed 38.7% KGav and 23.6% K_(L)a_(v) increase for 2M BEA-2M AMP with only HZSM-5 catalyst in desorber and a 95% K_(G)a_(V) and 45% K_(L)a_(V) increase for both K/MgO catalyst and HZSM-5 catalyst.This was attributed to the role of K/MgO in bonding loosely with CO_(2) and making it available for the amine reaction. | James Coker Daniel Boafo Afari Jessica Narku-Tetteh Raphael Idem | 2019 | Clean Energy2019，3，4： | 0 |
| 8 | Targeted co-delivery of daunorubicin and cytarabine based on the hyaluronic acid prodrug modified liposomes显示文摘Breast cancer is the most prevalent cancer in women,and it was hard to prevent or diagnose at an early stage.Thus,it is imperative to develop advanced therapeutics for effective treatment.Herein,a targeted daunorubicin(DNR)and cytarabine(ara-C)co-delivery system was developed by modifying the ara-C loaded liposomes(LIP-ara-C)with the hyaluronic acid-DNR(HA-DNR)prodrugs.The co-assembled hybrid nanoparticles(HA-DNR/LIP-ara-C HNPs)exhibited good serum and storage stability with an average diameter of approximately 100 nm.By specifically binding to the CD44 receptors that overexpressed on cancer cells,these HNPs could be uptake via endocytosis and accumulate intracellularly,in which an optimized DNR and ara-C combination at a molar ratio of 1:5 could generate enhanced synergistic effects with reduced dose-related toxicity on cancer cells. | George Frimpong Boafo Yejiao Shi Qingqing Xiao Kosheli Thapar Magar Makhloufi Zoulikha Xuyang Xing Chao Teng Emmanuel Brobbey Xiaotong Li Xiaohong Jiang Xiaochun Wang Yi Yang Samuel Kesse Wei He | 2022 | Chinese Chemical Letters2022，33，10： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员